OUT:JSEOUTsurance Group Limited Analysis
Data as of 2026-03-14 - not real-time
ZAC 7,255.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
OUTsurance Group posted a solid 13.6% revenue growth and an impressive 37% return on equity, underscoring strong earnings momentum. Operating margins of 17.3% and a profit margin near 12% highlight efficient cost management, while a dividend yield of 3.33% with a 66.5% payout ratio points to a sustainable income stream for shareholders. However, the current price of ZAc 7,255 sits well above the DCF‑derived fair value of ZAc 5,504, implying the stock is overvalued relative to its intrinsic estimate, a view reinforced by a P/E of 23.9 versus an industry average of 16.3. The balance sheet remains robust, with cash exceeding debt and a low debt‑to‑equity ratio, supporting the dividend and offering a cushion against market stress.
On the technical side, the price hovers around the 20‑day SMA (ZAc 7,260) and the RSI of 52 suggests a neutral stance, yet the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside pressure. Volume is on an upward trend, providing liquidity, and the stock’s beta of roughly 0.2 signals limited market‑wide volatility, though a 30‑day volatility of 28% indicates notable price swings. Together, these fundamentals and technical cues lead to a nuanced outlook: while the long‑term growth narrative is compelling, current pricing and bearish momentum temper short‑term enthusiasm.
On the technical side, the price hovers around the 20‑day SMA (ZAc 7,260) and the RSI of 52 suggests a neutral stance, yet the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside pressure. Volume is on an upward trend, providing liquidity, and the stock’s beta of roughly 0.2 signals limited market‑wide volatility, though a 30‑day volatility of 28% indicates notable price swings. Together, these fundamentals and technical cues lead to a nuanced outlook: while the long‑term growth narrative is compelling, current pricing and bearish momentum temper short‑term enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal indicating potential near‑term downside
- Current price above DCF fair value suggesting limited upside
- Stable dividend but high valuation may constrain short‑term returns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high ROE supporting earnings expansion
- Sustainable dividend yield of 3.33% with ample cash reserves
- Diversified geographic footprint reducing single‑market exposure
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust balance sheet with cash far exceeding debt
- Consistent profitability and high operating margins
- Long‑term insurance demand and fintech investments offering growth avenues
Key Metrics & Analysis
Financial Health
Revenue Growth13.60%
Profit Margin11.90%
P/E Ratio23.9
ROE37.10%
ROA13.71%
Debt/Equity3.30
P/B Ratio824.6
Op. Cash FlowZAC6.6B
Free Cash FlowZAC3.2B
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI52.5
SupportZAC 6,793.00
ResistanceZAC 7,693.00
MA 20ZAC 7,260.70
MA 50ZAC 7,146.14
MA 200ZAC 7,396.68
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueZAC 5,504.33
Target PriceZAC 8,430.00
Upside/Downside16.20%
GradeOvervalued
TypeBlend
Dividend Yield3.33%
Risk Assessment
Beta0.18
Volatility27.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.